Abpro HoldingsABPO +3.66%9 3-Year ROIIC % is -466.20 as of Dec. 2025. GuruFocus rates ABPO with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 1,327 Biotechnology companies, Abpro Holdings ranks worse than 88.47% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Abpro Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -466.20%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Abpro Holdings's 3-Year ROIIC % or its related term are showing as below:
ABPO's 3-Year ROIIC % is ranked worse than 88.47% of 1327
companies
in the Biotechnology industry
Industry Median: -4.82
vs ABPO: -466.20
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Abpro Holdings 3-Year ROIIC % Related Terms
Abpro Holdings 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Abpro Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABPO vs LYRA, ATXI, PTIX: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Abpro Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abpro Holdings 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Abpro Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Abpro Holdings's 3-Year ROIIC % falls into.
Abpro Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -4.051 (Dec. 2025) - -16.685 (Dec. 2022) )
/
( 0.314 (Dec. 2025) - 3.024 (Dec. 2022) )
=
12.634
/
-2.71
=
-466.20%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Abpro Holdings (ABPO) has a 3-Year ROIIC % of -466.20 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Abpro Holdings and its competitors. According to the industry distribution chart, Abpro Holdings ranks #1174 out of 1327 companies in the Biotechnology industry, placing it in the top 88.5%.
Is Abpro Holdings' 3-Year ROIIC % too high?
Abpro Holdings' current 3-Year ROIIC % is -466.20. Based on the distribution chart, Abpro Holdings ranks #1174 out of 1327 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Abpro Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Abpro Holdings' 3-Year ROIIC % compare to LYRA and ATXI?
According to the Biotechnology industry distribution chart, Abpro Holdings ranks #1174 out of 1327 companies for 3-Year ROIIC %. This places Abpro Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Abpro Holdings and its competitors. Abpro Holdings's current 3-Year ROIIC % is -466.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abpro Holdings stock overvalued right now?
Abpro Holdings (ABPO) has a current 3-Year ROIIC % of -466.20. The current 3-Year ROIIC % is -466.20. Abpro Holdings' overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Abpro Holdings (ABPO), the current 3-Year ROIIC % is -466.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. The company is focused on novel antibody constructs for immuno-oncology, ophthalmology, and infectious diseases. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, the company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
9GF Score
Get the complete analysis for ABPO
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABPO has been successfully added to your 
